Niklas Mattsson

Charles DeCarli, Clifford R Jack, Niklas Mattsson, 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease

Frederik Barkhof, Rik Ossenkoppele, Wiesje M. van der Flier, 2015, Neurobiology of Aging.

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Marina Boccardi, Niklas Mattsson, Kaj Blennow, 2017, Neurobiology of Aging.

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

Henrik Zetterberg, Niklas Mattsson, Kaj Blennow, 2017, EMBO molecular medicine.

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

Kevin Mills, Henrik Zetterberg, Niklas Mattsson, 2012, Biomarkers in medicine.

The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers

Giovanni B. Frisoni, José Luis Molinuevo, Aase Handberg, 2011, Alzheimer's & Dementia.

Reporting standards for studies of diagnostic test accuracy in dementia

Patrick M M Bossuyt, Henrik Zetterberg, Sascha Köpke, 2014, Neurology.

ASSESSING RISK FOR PRECLINICAL β-AMYLOID PATHOLOGY WITH APOE, COGNITIVE AND DEMOGRAPHIC INFORMATION

Michael W. Weiner, Niklas Mattsson, Oskar Hansson, 2016, Alzheimer's & Dementia.

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium

Leslie M. Shaw, Henrik Zetterberg, Pankaj Oberoi, 2013, Alzheimer's & Dementia.

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable

Clifford R. Jack, Prashanthi Vemuri, Susan M. Resnick, 2018, Alzheimer's & Dementia.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Norbert Schuff, Clifford R Jack, Niklas Mattsson, 2014, Brain : a journal of neurology.

Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?

Axel Petzold, Henrik Zetterberg, Niklas Mattsson, 2013, Clinical chemistry and laboratory medicine.

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

Henrik Zetterberg, Niklas Mattsson, Kaj Blennow, 2016, JAMA neurology.

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

Henrik Zetterberg, Niklas Mattsson, Kaj Blennow, 2018, Neurology.